58%
Finnrick rating
#2 of 233 Retatrutide vendors
2 of 8 classifiable tests passed
natural 25% · customers 4.3★ (26)
methodology · Purity focus
methodology →
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%6 Jun 2026: 81%22 Jun 2026: 76%22 Jun 2026: 72%13 Jul 2026: 68%13 Jul 2026: 64%13 Jul 2026: 60%14 Jul 2026: 56%20 Jul 2026: 58%25 Jul 2026: current 58%81%58%Jun 26Jul 26
Showing Retatrutide tests only
LP Peptide Retatrutide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
20 Jul 2026Pass
Tested
lab nameView COA
14 Jul 2026Fail
Tested
lab nameView COA
13 Jul 2026Fail
Tested
lab nameView COA
13 Jul 2026Fail
Tested
lab nameView COA
13 Jul 2026Fail
Tested
lab nameView COA
22 Jun 2026Fail
Tested
lab nameView COA
22 Jun 2026Fail
Tested
lab nameView COA
6 Jun 2026Pass
Tested
lab nameView COA

About LP Peptide test results from Finnrick

LP Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 12 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible LP Peptide peptides in this dataset are Retatrutide (8 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 12 recent tests.

Corrections
No corrections.